Pharmaceutical

Pharmaceutical Sector

Radiation: Danger, Safety and Diseases
Level 1

Radiation: Danger, Safety and Diseases
Level 1

Order Now! FOR FREE

Click here to show the index
  • 1. Introduction
  • 1.1. Definition of radiation
  • 1.2. Types of radiation
  • 1.3. Background radiation
  • 1.4. Nuclear power
  • 1.5. History of nuclear power plants; Accidents and safety
  • 2. Means of exposure
  • 2.1. Radiation exposure
  • 2.2. Radioactive contamination
  • 2.3. Irradiation vs contamination
  • 2.4. Radiation monitoring; Radiation doses considered to be safe; Personnel protection
  • 3. Medical aspects
  • 3.1. Major medical issues+radiation emergencies
  • 3.2. Initial lab Tests
  • 3.3. Acute radiation syndrome
  • 3.4. Cutaneous radiation syndrome (CRS)
  • 3.5. Medical management of internal contamination
  • 3.6. KI Blockage of Thyroid
  • 3.7. Stochastic effects
  • 3.8. Decontamination
  • 3.9. Psychological support and risk
  • 3.9.1. Immediate pshychological effects
  • 3.9.2. Long-term pshychological effects
  • 4. Medical countermeasures
  • 5. Appendix
  • 6. Bibliography




 


pharmaceuticals.png

Pharmaceutical Sector

Antibiotic resistance

Antibiotic resistance

Order Now!

Click here to show the index
  • 1. Introduction
  • 2. History of antibiotic
  • 3. The evolution of antibiotic resistance
  • 4. Antibiotic
  • 5. Classification of antibiotic
  • 6. Classification of bacteria
  • 7. Antibiotic resistance
  • 8. Brief Mechanism of Antimicrobial Resistance
  • 9. Different antibiotic resistant bacteria
  • 10. Genetics of resistance
  • 11. Ecological roles of antibiotics and antibiotic resistance
  • 12. Non genetic basis of resistance
  • 13. The Biological Side of Resistance
  • 14. The Pharmacological Side of Resistance
  • 15. The Biological Consequences of Resistance
  • 16. The Clinical Consequences of Resistance
  • 17. Cause of antimicrobial resistance
  • 18. Antibiotic resistance in different regions of the world
  • 19. Present situation of Resistance of different bacteria
  • 20. Prevention of antibiotic resistance
  • 21. The future for antibiotics and antibiotic resistance
  • 22. Conclusion




 


pharmaceuticals.png

Pharmaceutical Sector

Cardiomyopathy

Cardiomyopathy

Order Now!

Click here to show the index
  • 1.Introduction
  • 2.The heart
  • 3.Cardiomyopathy
  • 4.Major Risk factors of cardiomyopathy
  • 5.Types of cardiomyopathy
  • 6.Epidemiology
  • 7.Dilated cardiomyopathy:
  • 7.1 Pathogenesis
  • 7.2 Morphologic features
  • 7.3 Clinical features
  • 7.4 Investigations
  • 7.5 Treatment
  • 7.6 Prognosis
  • 8.Arrhythmogenic Right Ventricular Cardiomyopathy
  • 9.Hypertrophic cardiomyopathy:
  • 9.1 Pathogenesis
  • 9.2 Morphologic features
  • 9.3 Clinical features
  • 9.4 Investigations
  • 9.5 Treatment
  • 9.6 Differential diagnosis
  • 10.Restrictive cardiomyopathy
  • 10.1 Pathogenesis
  • 10.2 Morphologic features
  • 10.3 Clinical features
  • 10.4 Investigations
  • 10.5 Treatment
  • 10.6 Complications
  • 10.7 Diagnostic considerations
  • 10.8 Differential diagnosis
  • 11. Obliterative cardiomyopathy
  • 12. Prevention of cardiomyopathy
  • 13. Summery




 


pharmaceuticals.png

Pharmaceutical Sector

Denque fever

Denque fever

Order Now!

Click here to show the index
  • 1. Introduction
  • 2. Ebola History
  • 2.1. Etymology
  • 2.2. Emergence
  • 2.3. Recent Cases
  • 3. Virology
  • 3.1. Introduction
  • 3.2. Structure of Virion
  • 3.3. Genome
  • 3.4. Gene Expression
  • 3.5. Entry
  • 3.6. Replication
  • 4. Pathophysiology
  • 5. Immune Response to Dengue Virus
  • 6. Taxonomy
  • 7. Dengue classification
  • 8. Dengue virus Electron Micrographs
  • 9. Histologic findings
  • 10. Transmission
  • 11. Risk Factors
  • 12. Sign & Symptoms
  • 13. Diagnosis
  • 14. Differential Diagnosis
  • 15. Dengue Management
  • 16. Prognosis
  • 17. Prevention & Control
  • 18. Vaccine for Dengue
  • 19. Epidemiology
  • 20. Outbreaks
  • 21. Recent research and current focus
  • 22. Conclusion




 


pharmaceuticals.png

Pharmaceutical Sector

Ebola

Ebola

Order Now!

Click here to show the index
  • 1. Introduction
  • 2. Ebola Etymology
  • 3. Ebola History
  • 3.1. Emergence
  • 3.2. Recent Cases
  • 4. Virology
  • 4.1. Introduction
  • 4.2. Structure of Virion
  • 4.3. Genome
  • 4.4. Gene Expression
  • 4.5. Entry
  • 4.6. Replication
  • 5. Pathophysiology
  • 6. Immune Response to Ebola Virus
  • 7. Taxonomy
  • 8. Ebola Classification
  • 8.1. Zaire Ebolavirus
  • 8.2. Sudan Ebolavirus
  • 8.3. Reston Ebolavirus
  • 8.5. Bundibugyo Ebolavirus
  • 9. Ebola Electron Micrographs
  • 10. Histologic findings
  • 11. Transmission
  • 12. Risk Factors
  • 13. Sign & Symptoms
  • 14. Ebola Hemorrhagic Fever
  • 15. Diagnosis
  • 16. Diagnostic Considerations
  • 17. Differential Diagnosis
  • 18. Ebola Management
  • 19. Experimental Therapies
  • 20. Prognosis
  • 21. Natural Host of Ebola Virus
  • 22. Ebola Virus in Animals
  • 23. Prevention & Control
  • 24. Vaccine for Ebola
  • 25. Epidemiology
  • 26. Major Outbreaks
  • 26.1. 2007 to 2011
  • 26.2. 2012
  • 26.3. 2014 West Africa Ebola outbreak
  • 27. Demographics
  • 27.1. Age-related demographics
  • 27.2. Sex-related demographics
  • 27.3. Race-related demographics
  • 28. Recent research and current focus




 


pharmaceuticals.png

Pharmaceutical Sector

Gastric carcinoma

Gastric carcinoma

Order Now!

Click here to show the index
  • 1. Introduction
  • 2. The History of Gastric Carcinoma
  • 3. The Human Stomach
  • 3.1 Structure
  • 3.2 Blood supply
  • 3.3 Histology
  • 3.4 Functions
  • 4. Gastric Carcinoma
  • 5. Causes and risk factors
  • 6. Signs and symptoms
  • 7. Diagnosis
  • 8. Grading and classification
  • 9. Stages of stomach cancer
  • 10. Spread of stomach cancer
  • 11. Prognosis
  • 12. Management
  • 13. Follow up after treatment
  • 14. Supportive care
  • 15. Epidemiology
  • 16. Research and development
  • 17. Summary




 


pharmaceuticals.png

Pharmaceutical Sector

Hallitosis

Hallitosis

Order Now!

Click here to show the index
  • 1. Introduction
  • 2. Definition, causes, classification
  • 2.1. Definition
  • 2.2. Causes
  • 2.2.1. Oral and dental causes
  • 2.2.2. Medical causes
  • 2.3. Classification
  • 3. Diagnosis
  • 3.1. Self-diagnosis
  • 3.2. Professional diagnosis
  • 4. Treatment
  • 4.1. Dental Hygiene
  • 4.2. Antimicrobial Mouthwashes
  • 4.3. Periodontal Treatment
  • 4.4. Food and Water
  • 4.5. Medication
  • 4.6. Home remedies
  • 6. Social impact




 


pharmaceuticals.png

Pharmaceutical Sector

Hyperlipidemie

Hyperlipidemie

Order Now!

Click here to show the index
  • 1. Introduction
  • 1.1. Definition
  • 1.2. Description
  • 2. Classification
  • 3. Causes and risk factors
  • 3.1. Genetic causes
  • 3.2. Lifestyle causes
  • 3.2.1. Obesity
  • 3.2.2. Lack of exercise
  • 3.3. Risk factors
  • 4. Symptoms and tests
  • 4.1. Symptoms
  • 4.2. Tests
  • 5. Classification of lipid
  • 5.1. Classes of lipoprotein
  • 5.2. Lipid concentration
  • 6. Complication
  • 7. Treatment and therapy
  • 7.1. Statins
  • 7.1.1. Atorvastatin
  • 7.1.2. Fluvastatin
  • 7.1.3. Rosuvastatin
  • 7.1.4. Simvastatin




 


pharmaceuticals.png

Pharmaceutical Sector

Inflammatory Bowel Disease (IBD)

Inflammatory Bowel Disease (IBD)

Order Now!

Click here to show the index
  • 1. Introduction
  • 2. Crohn’s disease
  • 2.1. Definition and classification
  • 2.2. Causes, signs and symptoms
  • 2.3. Diagnosis and tests
  • 2.4. Treatment
  • 3. Ulcerative colitis
  • 3.1. Definition and causes
  • 3.2. Classification and symptoms
  • 3.3. Diagnosis and tests
  • 3.4. Treatment




 


pharmaceuticals.png

Pharmaceutical Sector

Malnutrition

Malnutrition

Order Now!

Click here to show the index
  • 1. Introduction
  • 2. Causes and Effects
  • 2.1. Causes
  • 2.2. Effects
  • 3. Symptoms and diagnosis
  • 3.1. Definition and symptoms of marasmus
  • 3.2. Definition and symptoms of kwashiorkor
  • 3.3. Diagnosis
  • 4. Treatment
  • 4.1. Treatment at home
  • 4.2. Treatment in hospital
  • 4.3. Treatment of marasmus
  • 4.4. Treatment of kwashiorkor




 


pharmaceuticals.png

Pharmaceutical Sector

MERS (Middle East Respiratory Syndrome)

MERS (Middle East Respiratory Syndrome)

Order Now!

Click here to show the index
  • 1. Introduction
  • 2. Etiology
  • 3. Virology
  • 4. Corona virus
  • 5. Epidemiology
  • 6. Pathophysiology
  • 7. Signs and symptoms
  • 8. Differential diagnosis
  • 9. Diagnosis
  • 10. Case identification
  • 11. Treatment
  • 12. Prevention
  • 13. Prognosis
  • 14. Recent research
  • 15. MERS outbreak update
  • 16. Conclusion




 


pharmaceuticals.png

Pharmaceutical Sector

Radiation: Danger, Safety and Diseases
Level 2

Radiation: Danger, Safety and Diseases
Level 2

Order Now!

Click here to show the index
  • 1. Introduction
  • 1.1. Definition of radiation
  • 1.2. Types of radiation
  • 1.3. Background radiation
  • 1.4. Nuclear power
  • 1.5. History of nuclear power plants; Accidents and safety
  • 2. Means of exposure
  • 2.1. Radiation exposure
  • 2.2. Radioactive contamination
  • 2.3. Irradiation vs contamination
  • 2.4. Radiation monitoring; Radiation doses considered to be safe; Personnel protection
  • 3. Medical aspects
  • 3.1. Major medical issues+radiation emergencies
  • 3.2. Initial lab Tests
  • 3.3. Acute radiation syndrome
  • 3.4. Cutaneous radiation syndrome (CRS)
  • 3.5. Medical management of internal contamination
  • 3.6. KI Blockage of Thyroid
  • 3.7. Stochastic effects
  • 3.8. Decontamination
  • 3.9. Psychological support and risk
  • 3.9.1. Immediate pshychological effects
  • 3.9.2. Long-term pshychological effects
  • 4. Medical countermeasures
  • 5. Appendix
  • 6. Bibliography




 


pharmaceuticals.png

Pharmaceutical Sector

Tropical disease

Tropical disease

Order Now!

Click here to show the index
  • 1. Introduction
  • 2. African trypanosomiasis
  • 2.1. Definition, signs and symptoms
  • 2.2. Life cycle
  • 2.3. Treatment
  • 3. Chagas disease
  • 3.1. Definition, signs and symptoms
  • 3.2. Life cycle
  • 3.3. Treatment
  • 4. Malaria
  • 4.1. Definition, signs and symptoms
  • 4.2. Life cycle
  • 4.3. Treatment
  • 5. Leprosy
  • 5.1. Definition and symptoms
  • 5.2. Pathophysiology
  • 5.3. Treatment
  • 6. Lymphatic filariasis
  • 6.1. Definition, signs and symptoms
  • 6.2. Life cycle
  • 6.3. Treatment




 


pharmaceuticals.png

Pharmaceutical Sector

Zika Virus

Zika Virus

Order Now!

Click here to show the index
  • 1. Introduction
  • 2. History of Zika virus
  • 3. Virology
  • 4. Structure
  • 5. Reproductive Cycle of a Zika virus in a Host Cell
  • 6. Transmission
  • 7. Symptoms of Zika virus
  • 8. Diagnosis
  • 9. Treatment
  • 10. Prevention
  • 11. WHO response
  • 12. Zika virus-WHO declares global public health emergency
  • 13. Zika and pregnancy- Raising questions and answers
  • 14. Zika virus and breastfeeding
  • 15. What are Dengue, Zika, and Chikungunya?
  • 16. Guillain-Barré syndrome and Zika virus
  • 17. Research on Zika virus
  • 18. Conclusion
  • 19. References




 


Back to Top